Cara Therapeutics, Inc. (CARA) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. My name is Josh and I will be your conference facilitator. I would like to welcome everyone to the CARA Therapeutics fourth quarter and full year 2022 financial results and update conference call. All lines have been placed on mute to avoid any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star and the number 11 on your telephone keypad. Please be advised that this call is being recorded. I would now like to introduce Matt Murphy, CARA's Manager of Investor Relations. Mr. Murphy, you may begin your call. Thank you, Operator, and good afternoon. Just after market closed today, CARA issued a news release announcing the company's results for the fourth quarter and full year 2022. Copies of this news release and the associated SEC filing can be found in the investor section of our website at www.caratherapeutics.com. Before we begin, let me remind you that during the course of this conference call, we will be making certain forward-looking statements about CARA and our programs based on management's current plans and expectations. These statements are being made under the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties. Actual results may differ materially due to various factors, and CARA undertakes no obligation to update or revise these statements publicly as a result of new information or future results or developments. Investors should read the risk factors set forth in CARES 10-K for the year end of December 31st, 2022, and any subsequent reports filed with the SEC. With that said, I'd like to turn the call over to Chris Posner, CARES Chief Executive Officer. Chris? Thanks, Matt, and good afterno...